The effect of acupuncture with electrical stimulation on the plasma acth and corticosterone levels of morphine addicted rats and mice. by Tsang, Yu-fui. & Chinese University of Hong Kong Graduate School. Division of Biochemistry.
THE EFFECT OF ACUPUNCTURE WITH ELECTRICAL
STIMULATION ON THE PLASMA ACTH AND CORTICOSTERONE
LEVELS OF MORPHINE ADDICTED RATS AND MICE
电 针 疗 法 对 有 吗 排 毒 瘾 之 大 小 白 鼠 血 浆 内
促 臂 上 腺 皮 质 激 素 及 皮 质 固 酮 含 量 之 效 应
BY
YU-FUI TSANG
B.A. (HUMBOLDT STATE UNIVERSITY, CALIFORNIA, U.S.A.)
A THESIS SUBMITTED IN PARTIAL FULFILMENT OF






THE CHINESE UNIVERSITY OF HONG KONG

We accept this thesis as conforming to the













TO MY MOTHER COUNTRY
TIIF MAGNIFICENT CHINA
This thesis was based on the work of a project,
directed by Dr.H.L.Wen,Professor L.Ma and Dr.
W,-W.Tso on the Bicchemical Basis of Acupuncture
in the Treatment of Addiction. Part of the work
has been presented in the 4th International confer-
ence on Alcoholism and Drug Dependence (Liverpool,
Enland;1978)by Wen et al.and in the Biochemical
and Biophysical Research Commonications by Choy et al.
(in press). The manuscript on the results of the
experimentation on rats of this thesis is in
preparation and will be submitted for publication
by Tso et al.shortly.
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ABSTRACT
Acupuncture with electrical stimulation (AES)
has been employed to alleviate withdrawal from morphine
addicts in rehabilitation programs being practised in
Hong Kong and Taiwan. It has been found that there are
significant changes in plasma ACTII and cortisol levels
in the patient at various stages in the rehabilitation
program. The airn of this investigation is to establish
an animal model for further biochemical studies.
Using rats to construct an animal model, a con-
dition can be reached by intraperitoneal injection of
morphine twice daily for a period of 2 weeks, followed
by an injection of 0.01 mg of naloxone which gives a
withdrawal syndrome comparable to that observed in
addicted patients. This withdrawal syndrome can be
a-lleviated by AES resemble the procedure practising in
clinical rehabilitation program. Similar condition
was found with laboratory mice. In general, the effect
of AES brings about a suppression of the naloxone-
precipitated withdrawal syndrome which is also demon-
strated by a substantial reduction of the already ele-
vated plasma ACTH and CS levels.
Experiments with chronic addicted rats abstained
from morphine for 14 hours (whose withdrawal symptoms
are less extreme in magnitude than that induced by
the injection of nalox one) show a depression of their
plasma biochemical contents. On applying AES, this
depressed plasma biochemical levels was restored.
The alleviation of withdrawals in both withdraw-
ing classes with opposite changes in plasma biochemicals,
an increase in natural withdrawal class and a reduction
in naloxone-precipitated withdrawal class suggest a




I.Aim of this Investigation
II.General Review
A.The pituitary-adreal axis
B.Effect of the pituitary-adrenal
axis
C.Morphine analgesia and acupuncture anal-
gesia
MATERIALS AND METHODS





A.Determination of plasma ACTH
B.Determination of lasma Corticosterone
RESULTS AND DISCUSSION
Section A:Experiments with Rats






















I. AIM OF THIS INVESTIGATION
Apart from the conventional drug rehabilita-
tion methods employing the narcotic antagonist therap:
or the replacement therapy, acupuncture with electricel
stimulation (AES) has been introduced to detoxify drug
addicts in hiong Kong (Wen and Cheung, 1973 a&b) and
Taiwan (Chen et al., 1976) since 1973. This simple,
economical and relatively short term treatment has
soon raised interest from different research teams,
with the potential of being developed into the most
successful method ever applied to rehabilitate drug
addicts.
A previous study conducted by our group to
follow the biochemical changes in blood and urine
of heroin addicts treated by AES showed that after
initial AES treatment, the plasma levels of Adreno-
corticotropic hormone (ACTH) and cortisol in heroin
addicts were reduced but not in the normal group
(Harms, 1975 Ho et al.9 1977b).
Numerous reports that acupuncture has been
successfully applied to a great varieties of mammals
including rat and rabbit strongly suggest that its
biochemical effects may transcend animal origin
(Wen et al., 1977 Lung et al., 1973 Research group
2of Acupuncture Analgesia, 1971). In this research,
we have extended our observation to two laboratory
animal types, namely rat (Sprague--Dawley Strain) and
mouse (UMT Strain).
The first part of this investigation, the es-
tablishment of the animal model was done in collabo-
ration with my colleague Mr. H. K. Wong. The behavioral
study showed that addicted rats and mice treated with
AES resulted in a reduction of the withdrawal scores.
Plasma levels of ACTH and corticosterone (CS) mea-
surements however, indicate that AES creates a regula-
ting effect instead of unidirectional change in the
biochemical level.
For the benefit of discussion, a general know-
ledge about the pituitary-adrenal axis, morphine
addiction and acupuncture analgesia is revised in
the following paragraphs.
II, GENERAL REVIEW
A. The pituitary-adrenal axisr wraea.r. ..ow .+M r- ay
ACTH has been isolated from sheep pituitaries
and the complete structure of the polypetide was
identified by Li et al. (1954 1955) in 1954 respec-
tively. It is a single-chain polypetide composed of
39 amino acids with molecular weight of approximately
34, 500. The 1-24 amino acid of ACTH are similar in dif-
ferent species. Variations occur from 25-39 amino acid
of ACTH among different species. The ACTH activity is
found to be resided in the N-terminal 1-19 amino acid
portion of the polypetide chain (Li, 1962).
ACTH is secreted by chromophobe cells in the adeno-
hypophysis (Siperstein and Miller, 1970). It ,is released
into the circulatory system and carried to the adrenal
cortex where it stimulates the release of glucocorticoids.
ACTH is released upon stimulation of the adenohypophysis
by corticotropic releasing factor (CRF). According to
Brodish (1972) there are two types of CRS`, the hypothala-
mic CRF in the brain and the extrah ypothalamic CRF in
peripheral blood. The extrahypothalamic CRF is suspected
to play a role in sustaining elevated level of ACTH dur-
ing periods of prolonged severe stress.
The control mechanism of ACTH is fairly complicated
and can be categorized into four mechanisms:
a. A diurnal rhythm maintained by biological clock in
the temporal lobe:- this is a programmed sequence of
events under the central nervous system (CNN) cont-
rol. There are episodic secretion within the whole
day but the main secretion periods are during the
6-8 hour of sleep and first hour after awake.
b. A short feedback-mechanism exerted by action of ACTH
on the hypothalamus:- this mechanism is important for
4the fine adjustment of pituitary act ivi.ty.
c. A close loop interaction of the cost .coc teroicd--
ACTH-CRi completed by the negative feedback of
corticosteroid.
d. Stress causing excitatory neural irnput,s converged
on the hypothalamus resulting in ACTH secretion:-
this can override the feedback control of gluco-
corticoids. Stress can be distinguished as neuro.-
genic stress which is transmitted through CNS, and
systemic stress which is transmitted through humor-
al mechanism.
The integrated control of all these mechanisms
provides the organism with the ability to deal with re-
gular daily processes and to react against emergency
condition.
The biological properties of ACTH are quite div-
ersified and are still under investigation. The most
obvious effect is the action on the adrenals and the
release of corticosteroids. Li (1962) has summarized
the functions of ACTH, both in vivo and in vitro, and
are reproduced in Table 1.
Recent research reveals some interesting func-
tions of ACTH fragments and analogues in acquisition
and maintenance of conditioned behavior. Leshner and
Roche (1977) showed that ACTH treatment enhanced avoi-
5Table 1. Some Biological Properties of ACTH
Experimeatal
condition Eiological effects of ACIH
1. increases the weight of adrenal glands
2. Repairs the adrenal of hypophysectomized rats
3. Promotes corticoid production ad estimated in the adrenal
venous blood
4. Ckauses eosinopenia and thymic involution
5. Enhance4s erythropoiesis in hypophysectomized animals
6. Elevates metabolic rate of hypophysectomized rates
7. Induces deciduoma in hypophysectomized-oophorectomized
rats
8. Increases weights of sex accessories of hypophysectomized-
castrated rats
9. Maintains muscle glycogen in hypohphysectomizxed animals
10. Provokes glycogen deposition in the liver
11. Acts as a galactopoietic agent
12. Exerts antagonistic action to growth hormone
13. Causes and increase of liver fat in fasted animals
14. Induces an elevation of serum-free nonesterified fatty acics
15. Increases blood ketone bodies in fasted rats
16. Stimulated melanophore expansion in amphibians and
reptiles
17. Suuppresses the increased capillary permeability induced
by exudin
18. Causes an increase in liver fat in animals maintained
with corticoids
19. Produces hypergranulation of the renal juxtaglomerular
cells
20. Influences metabolism of cortisol
21. Stimulates corticosterone production in the rat adrenal
and aldosterone production in the bullfrog adrenal
22. Causes melanephore expansion in skins of amphibians and
reptiles
23. Releases peaesterified fatty acids from rat epididymal
fat pad
24. Induces the uptake and oxidation of glucose by rat
mannary tissue
25. Inhibits incorporation of amino acids into adipose-
tissue protein
In vivo




6dance retention no matter the hormone was injected
to the rat prior to training, just following acqui-
sition or 24 hours after acquisition. The facilita-
tory effect of ACTH treatment sustained for 24 hours
but not 240. De Wied (1976) postulated that ACTII
fragments affect the behavior by a temporary selective
increase in the state of arousal in limbic midbrain
structures, thereby increasing the motivational
influence of environmental stimuli.
Another newly discovered property of ACTH is
the exhibition of binding affinity to opiate receptors
(Gispen et al., 1975 1976 Terenius et al., 1975
Terenius, 1976). Terenius et al. (1975) have confirmed
that the N-terminal fragments of ACTH have an affinity
for rat brain opiate receptors in vitro. The ACTH
4-10 fragment is crucial. These peptides are devoid
of corticotropic activity and inhibit morphine induced
analgesia. The peptides show a partial agonist-
antagonist properties. The concentration giving 50%
inhibition of the binding of 7,9- (3H)-d3_tiydroi:torphine
to the synaptic plasma membrane fraction is 10-5m
which is much higher than morphine (10-9 M). Taking
this into consideration, Terenius concluded that the
peptides are not likely to be important endogenous
opiate receptor ligands in physiological condition
7and even though these fragments are present in
sufficient concentration, their partial agonistic
features suggest merely a modulatory role.
Cuillemin et al. (1977) discovered in 1977
that both B-endorphin and ACTH are secreted concomi-
tantly by the pituitary gland in normal rat. This
gives rise to a suggestion both B-lipotropin and
ACTH are derived from a common precursor. However
a different result was reported by Krieger et al.
in 1977 who found a different distribution pattern
of B-lipotropin and of ACTH in discrete areas of
bovine brain. This can either be due to independent
synthesis, or differential distribution of degrada-
tive enzymes (or uptake sites) for these two peptides.
What is the function of[ -endorphin in periphery and
how is it related to the function of concomitantly
secreted ACTH still awaits further research work
to disclose.
Corticosterone (CS) is the glucocorticoid
secreted exclusively by rats and mice from the adrenal
cortex. It is synthesized from cholesterol and belongs
to the group of C-21 steroid. Upon stimulation by
ACTH, CS is secreted from the adrenal cortex into the
circulatory system and is transported by binding to
transcortin (a-glubolin). There is very little free
corticosteroid in plasma and the bound CS is physically
8inactive. It serves as a reservoir for free C.S. CS
is metabolized in liver where it is conjugated into
glucuronic acid and excreted in urine. The main
function of CS is to regulate the energy utilization
of cells and affects water, carbohydrate, protein and
fat metabolism inside the body. It also plays a
main role in resistance to stress. An adrerialecto-
mized animal dies when exposed to oven a minor stress.
CS secretion is triggered by ACTH and in re-
turn, CS has a negative feedback control on stress
induced ACTH secretion. The mechanism is biphasic
in nature (Dallman and Jones, 1973), acutely the
rise of CS stimulated by increased ACTH levels acts
through a rate-sensitive path to rapidly limit the
duration of ACTH secretion while chronically, 2 or
more hours after CS levels have been elevated, there
is a decrease in the amount of ACTH secreted in res-
ponse to stress. This second period of inhibition is
independent of the CS levels. CS nay also be involved
in acquisition and maintenance of conditioned behavior.
De Wied (1976) proposed that CS works together with
ACTH and affects conditioned behavior by altering the
arousal level in limbic midbrain structures to enhance
discrimination and consequently the elimination of
irrelevant behavioral responses. lie suggests that
neuropeptides related to ACTH play a basic role in
motivational, learning and memory processes while
the pituitary-adrenal system, through the secretion
of corticosteroids, carries a secondary modulatory
function.
B. Effect of opiates on the pituitary-adrenal axis
Upon prolonged exposure to narcotic analgesics,
physical dependence and tolerance will develop.
Physical dependence is characterized by the abrupt
termination of the drugs causing a predictable and
reproducible syndrome to appear. Tolerance is defined
as a necessity of ever-increasing doses of drug to
achieve responses equal in magnitude to the initial
effect. The narcotic analgesics composed of morphine,
methadone, heroin and other chemica iiy synthesized
drugs with similar properties. There is another class
of compounds wrhich antagonized the action of the
narcotics and is known as the antagonist. Naloxone
is a pure antagonist. Between the pure agonists and
antagonists, there are a number of agents -which produc
analgesia in man and can also inhibit or reverse the
effects of one of the pure analgesics. Pentazocine
and nalorphine are examples of drugs in this category
(for structures, see Figure 1).
The appearance of severe withdrawal symptoms
during cessation of drugs strongly implies the dis¬
turbance of the body by the action of the drugs. Re-
9
Fig, 1. Some Typical Examples of Pure Agonist, Mixec
Agonist-antagonist and Pure Antagonist
10
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cent research on identifying opiate-like substances
such as -endorphin, enkephalins (Cox et al., 1975;
Hughes et al., 1975), and opiate receptors (Pert and
Snyder, 1973 Kuhar et al., 1973) present in the
brain has precipitated an idea that the exogenous
opiates bind to the opiate receptors thus exerts
an analgesic action. At the same time, the regular
rhythm of different systems inside the body are dis-
rupted (Christian, 1972; Gisburg and Cox, 1972 ;alsh
1972; Smith, 1972 ;Simon, 1972). Among different
systems being affected, the pituitary-adrenal axis
is one of them.
The effect of opiates on the pitu itary- c`...
axis can be differentiated into an acute and
effect. It has long been found that a eingie
cr morphine in rats stimulates the Seers-I.-Jon o
and subsequently CS (Briggs and Munson, 1955;ceorge
and Way, 1955). This effect of morphine is depender
upon an intact pituitary-adrenal axis since it is
abolished by hypophysectomy (George and ,ray,, 1955)
There is evidence indicating that morphine activation
of ACTH secretion is mediated via a direct action on
the rostral regions of the hypothalamus and median
eminence (George and Way, 1959). In 1969, Lotti et
al. (1969) employing the intrahypothalamic adminis-
tration technique localized an area in the middle
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region of the hypothalamus where focal injection of
morphine (5-50 ug) produced a marked reduction of
adrenal ascorbic acid and an elevation of plasma CS.
In summary (George and Lomax, 1972), it appears that
the acute administration of morphine may:
a. Produce a stress-like response by depletion of
adrenal ascorbic acid or elevation of plasma
corticosteroids.
b. Inhibit ACTH release in response to stress.
c. Block the diurnal rise of plasma corticoster-
oids.
Chronic administration of morphine produces
inhibition or tolerance to its effects on ACTH secre.
tion and reduces adrenal corticosteroid secretion
in man (Eisenman et al.', 1961) and rats (Parole and
Melchiorri, 1961 Ho et al., 1977b). Ei s enman et al
(1962) found that morphine interfered with the early
morning rise of plasma 17-hydroxycorticosterone.
Moreover Cushman et al. (1970) and Kokka and George
(1974) recently showed that stressful stimuli cause
a significant increase of plasma CS suggesting the
CNS response to stress is still functioning.
During withdrawal, eithe abrupt or naloxone-
precipitated, there is an increase in both plasma
ACTH and CS. The maximal rise in adrenal cortical
14
levels correlates well with the peak physiological
effects of the abstinence syndrome, approximately
48 hours after withdrawal (Eisenman et al., 1961).
In general, the effect of opiates on the pituitary-
adrenal axis is firmly recognized whereas how does
these changes take place is still an open question.
C. Morphine analgesia and acupuncture analgesia
Morphine has been employed as analgesic
centuries ago and is still one of the most potent
reagents for relieving intractable pain. Acupuncture
analgesia has only been developed in China during the
fifties. Since then a lot of work has been done
trying to correlate the analgesic effect of acupuncture
with that of morphine and to find out the mechanism
of analgesia. Recently Omura (1976) summarized the
similarities and differences between analgesia pro-
duced by morphine and acupuncture. The only signifi-
cant common effects between the two are analgesia,
euphoria, sedative effects for hyperactivity or
irritability and hyperglycemia effect. It was also
noted that the effect of acupuncture depends greatly
on the original condition of the body: with morphine,
blood pressure often decreases while with acupuncture
(O'Connor and Bensky, 1975), in subjects with normal
or high blood pressure, the blood pressure often
15
decreases but, in those with low blood pressure,
the change is a significant elevation towards normal,
Acupuncture analgesia does not show any respiratory
depression which is always accompanied with morphine
analgesia. Moreover, analgesia produced by morphine
acts on the whole body of the organism while acu-
puncture analgesia usually produces a localized effec
Another important characteristic of acupuncture anal-
gesia is the necessity of an induction period for its
action. This is most obvious when acupuncture is
employed to treat drug addicts and in surgery.
In view of the recent discoveries of morphine-
like peptides inside the brain, it is expected that
the morphine action and the acupuncture effects may
share some path in common (Lung et al., 1973 Research
Group of Acupuncture Anaesthesia, 1974 Pomeranz and
Chiu, 1976 Sjolund et al., 1977). Even though ex-
perimental results have actually been shown indica-
ting that acupuncture analgesia can be blocked by
administration of naloxone, a pure antagonist to
morphine analgesics (Pomeranz and Chiu, 1976 Mayer
et al., 1977), there are still many problems in es-
tablishing the interrelating pathway of the two
analgesic effects. In China, acupuncture has long
been employed beneficially to cure various kinds of
sickness (O'Connor and Bensky, 1975 lien and Chau
30
1973 Shuaib and Haq, 1977 Yu and Lee, 1976 Tsuei
et al., 1977). How can these effects be explained
by a mechanism correlating morphine action and
acupunctural effects is still not in sight. It is
conceivable that analgesia is only part of the
distinguish properties of acupuncture. Hopefully,
a study of the AES action on morphine addicted
animals may shed some light on the disclosure of
the general mechanism Of acupuncture. This will
provide a better foundation for the investigation




I. METHODS EMPLOYED TO INDUCE MORPHINE ADDICTION
Female rats of Sprague-Dawley Strain weighing
200-250 gm were used throughout the experiment. These
rats were raised in a light (6:00-18:00 hour), tempe-
rature and humidity regulated environment. To prevent
unnecessary stress generation, 10 rats were housed in
each cage. Food and water were administered ad libitum.
During the first part of the project, daily injection
of morphine was used to addict the rats. This procedure
is outlined in Table 2. The entire period of addiction
was 8 weeks. Fourteen hours after the last adminis-
tration of morphine, usually in the following morning,
these addicted animals were employed for experimentation.
In the latter part of the experiment, naloxone was
introduced to precipitate the withdrawal syndrome, as
suggested from our clinical observation. Under this
condition, exceedingly shorter period, two weeks in-
stead of eight, is adequate to create a suitable chronic
morphine addiction state for AES treatment. For con-
venience, this modified schedule was followed eversince
(Table 3).
Female mice of WHT Strain (British) weighing
25-30 gm were bred in our animal house under the same
condition as described for the rats. These animals
18
Table 2. Chronic Morphine Addiction Schedule for Rats
Date Time Dosage in mg/Kg
1st 8:00 a. m. 9
8:00 p.m. 5
2nd 8:00 a.m. 10
8:00 p.m. 10
3 rd 8:00 a. m. 15
8:00 p.m. 15
4 th 8:00 a.m. 20
8:00 p.m. 20
5 th 8:00 a.m. 2
8:00 p.m. 25
6 th 8:00 a.m. 30
8:00 p.m. 30
7 th 8:00 a.m. 35
8:00 p.m. 35
8 th 8:00 a.m. 40
8:00 p.m. 40
The same dosage was used after the eighth day for about
seven more weeks to prepare the rats for experimentation.
19
Table 3. Modified Morphine Addiction Schedule for Rats
Dat Time Dosage in mg/Kg
1st 9:00 a.m. 5
5:00 p.m. 5
2 nd 9:00 a.m. 10
5:00p.m. 10
3 rd 9:00 a.m. 20
205:00 p.m.
4 th 9:00 a.m. 40
405:00 p.m.
The same dosage was used after the fourth day for about
ten more days to prepare the rats for experimentation.
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were rendered dependent on morphine by a subcutaneous
implantation of 2 morphine pellets with an interval
of 24 hours. The morphine pellets were prepared and
implanted according to the methods of Hui and Roberts
(1975). Each pellet contained 15 mg morphine hydro-
chloride. To ensure higher percentage of the experi-
mental mice to be addicted, a screening procedure for
responders was used (Simantov and Snyder, 1976). The
animals were injected intraperitoneally with 10 mg/Kg
naloxone (Endo Lab. Inc., N.Y.) 24 hours after the
second implantation. Mice which showed jumping move-
ment during a 15-minute observation period were selec-
ted and pellets were removed after this screening ex-
periment. The jumpers were further stabilized for
one week and rendered morphine dependent again by
pellet implantation in exactly the same manner. The
mice thus selected were found to show higher with-
drawal scores on naloxone precipitation.
II. BEHAVIOR ASSESSMENT
In the first part of this research, special
attention was paid to assimilate the clinical condi-
tion for heroin addiction in human subjects. Naloxone
was not introduced in this period and withdrawal syn-
drome was merely due to abrupt abstinence from mor-
phine for 14 hours. The withdrawal symptoms were
21
expressed as :teeth chattering, wet dog shakes
(brief episodes of rapid repetitive shaking of the
entire trunk, sometimes the animal shakes so vio-
lently that it may lose its balance)' lacrimation
along with salivation, ptosis, squealing on touch or
vocalization, diarrhea, and hyperactivity which is
manifested by restlessness, increased exploratory
behavior, rearing on hind legs, paw tremor, sniffing
or digging and repeated attempts to escape from the
container (Wei, et al., 1973 Cicero and Meyer, 1973)
Of these various signs of withdrawal, wet dog shakes
teeth chattering, attempts to escape, abnormal pos-
turing and diarrhea (Fig. 2) were among the most obvious
and easily quantitized ones at the abstinent state in
the rat. These parameters were thus used as a quan-
titative assessment throughout the behavioral studies.
Is was found that naloxone-precipitated withdrawal
system was generated at a more controllable manner
than that from the natural morphine abstinent with-
drawal. Unless specified, the behavior of the rats
were observed for a 30-minute period before sacrifi-
cation for biochemical studies.
Withdrawal of addicted rsice was induced by
intraperitoneal injection of na:oxone. Mice treated
accordingly showed more repeated jumping and tremor
22
Fig. 2. The Abnormal Posturing of Rat Suffering
from Withdrawal, the Rat also had
Serious Diarrhea
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of the forelimbs (Fig. 3) while other symptoms such
as hyperactivity are similar to the rats if not
identical. This is in agreement with Maggiolo and
Huidobro's observation (1961). The degree of with-
drawal was assessed by counting the total scores of
jumping, abnormal posturing, diarrhea and paw trem-
oring in 15 minutes.
III. AES TREATMENT
Different size acupuncture needles of 2 inches
long (guage 30) and 0.5 inch long (guage 34) were
used for rats and mice correspondingly. Since the
stimulation was generated electrically instead of
manually, the acupuncture needles were slightly
modified for this purpose (Fig. 4). The electrical
stimulator (Biopulse Ltd., H.K.) generates a biphasic
pulse with a frequency of 120 Hz. This is the same
kind of stimulator employed in treating drug addicts
(Wen and Cheung, 1973 a&b).
Morphine dependent rats were prepared for AES
treatment a night before experimentation by having
the acupuncture needles inserted into the conchae of
both ears precleaned with an ethanol cotton swab.
It was found that the point o1 insertion of the needle
is not very critical and in general the conchae posi-
tion was chosen which corresponds to the lung point
24
Fig. 3. Jumping Behavior of Mice Resulted from Naloxone-precipitated
Withdrawal
25
Fig. 4. Wiring Parts for AES Treatment
A, acupuncture needle B, rubber
fastener C, plastic tube for insulation







of human being. To ensure the needles do not slip
during treatment, rubber fasteners were used. The
animals with needles inserted into both ears re-
quired presumably an adequate period of rest to get
used to their new features. They were then stabilized
overnight in an undisturbed location. During this
period, only water was supplied. In the next morning,
the pointed end of the acupuncture needle in the AES
treated group was connected to the stimulator mentioned
above. Precautions were also taken to prevent poor
connection as well as injury of the rat due to vigo-
rous agitations and violent movements. During the
early part of the research, a voltage of 3-4 volts
was used. The voltage was found to be slightly higher
than needed (see results) but creates in general Si-
milar results. To differentiate it from the lower
voltage adopted in later experiments, this voltage was
designated as high voltage. A lower voltage (0.5 or
less) was used in later part of the experiments in
rats. This low voltage was also used throughout all
experimentation with mice.' The rats receiving AES
treatment were primed with AES for an hour prior to
naloxone injection, and followed by AES treatment
for another 30 minutes in the observation period (Fig.
5). Immediately after behavioral observation, the
27
Fig. 5. Rats under AES Treatment
The rat in the right hand
tray was used as control (without
AES treatment).
28
rats were decapitated and blood samples were
collected in heparinized tubes and stored in an
ice-bath for further investigations. Aliquots of
the plasma samples were taken out for different
biochemical assays.
Similar AES procedure was employed in mice
except the needle insertion was carried out imme..
diately, without a period of stabilization before
the experiment. This modification was taken because
mice reacted so violently to needle insertion that
overnight stabilization will only increase the
risk of damage to the needles as well aE to the
animals themselves. The priming period of mice
receiving AES was 30 minutes. A 15 minute obser-
ration period was followed. Because tai arnplc size,
:he plasma collected from the mice were cooled
together for ACTH assay.
IV. ASSAY METHODS
A. Determination of Plasma ACTH
Radioimmunoassay kits (Code IM.66) from the
Radiochemical Centre, Amersham, England were employec
for the determination of plasma ACTH in all animals.
These kits showed high sensitivity in the determina-
tion of ACTH in plasma over a concentration range
of 10-4,000 pg/ml (Table 4). Since rats have a
29































higher plasma ACTH level than clinical samples, 0.7
ml plasma is sufficient for the assay. The assay
procedures are outlined schematically in Fig. 6.
For each batch of samples, a standard curve was
constructed. The labelled free ACT!! was counted by
a Gamma Counter (Nucleus, Inc., Oak Ridge, Tenn.).
The percent standard error for total count of 10,000
is 2%. The level of ACT!! in the sample is calculated
by:
pg ACTH /ml plasma= c x V/5 x 700/v
700/v
where c= interpolated concentration from
standard curve.
V= volume of unknown plasma sample (ml).
v= volume of extract solution used (ul).
B. Determination of plasma CS
Corticoids fluoresce when treated with con-
centrated sulphuric acid (Bauld et al., 1960 McLau-
ghlen et al. 1958). Essentially, plasma CS was
determined by the fluorometric method employed by
Guillemin et al. (1959). The spectrofluorometer
(Turner Model 430 Palo Alto, Calif.) used is
capable to determine quantities of substance in
nanogram level thus only 0.4 nil plasma sample is
needed for each assay. The procedures of preparing
31
Sample (0.7 ml plasma)




wash with water, then IN HC15
eluted with 50% acetone
T
1.5 ml eluant
dry down and redissolve in buffer
aliquots for RIA
+ antiserum
incubate for 16-20 hours at 4 C
+ labelled ACTH




discard inbounded ACTH counted
by Gamma Counter
Fig. 6. Protocol Used In Preparing Plasma Samples For ACTH
Radioimmunoassay
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analysis sample are outlined schematically in Fig.
7. The precision and accuracy of these tests are
monitored in Table 5.
33
Sample (0.4 ml plasma or less)





1: 2 2 v/v)
V
remove aliquots for assay ofI
CS content
conc. sulphuric acid :ethanol
(7:3, v/v)
stand for 30 minutes
read fluorescence at 470/525 nm
Fig. 7. Protocol Used In Preparing Plasma Samples For
Corticosterone Fluorometric Assay
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*Actual value of control samole is 71.4.
RESULTS AND DISCUSSION
Section A: EXPERIMENTS WITH RATS
Plasma ACTH and CS levels in chronic morphine
addicted rats, Clinical observation from this group
has demonstrated that the plasma ACTH levels in human
drug addicts are lower than healthy normals. Experi¬
mental studies by Parole and Melchiorri (1961) with
rats have suggested similar findings. In the labora¬
tory animal chosen namely rats and mice, plasma ACTH
and CS levels of control and morphine addicted rats
were analyzed, A period of 8 weeks of addiction was
chosen based upon the knowledge obtained from human
subjects as well as behavioral observations, A
comparison of these mean values depicted in Table 6
indicates that the plasma ACTH level of the morphine
addicted rats is reduced by 4l.7 The test of sig¬
nificance,, as calculated from the Student's t test
shows a slightly higher p value, between 0,05-0.1,
Taken into consideration that similar studies with
mammals have shown ACTH depression in morphine
addicted individuals (Parole and Melchiorri, 191;
McDonald et al., 1999; Ho et al,, 1977b) and that
the CS levels which are usually good reflection of
the ACTH levels do demonstrate ?uch a reduction. The
results thus obtained should be regarded as consistent
35
Table 6. Plasma ACTH arid Corticosterone Levels in Control and Morphine Addicted Rats
Compound: Control Morphine Addicted Rats Test of
Values in parentheses are units of concentrations.
The significance level of the difference was evaluated by the Student's t test.
8 weeks of addiction, 4 hours after last dose of morphine injection.
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with a reduction of plasma ACTS-i in addicted animals.
The plasma CS level in morphine addicted rats
indicates significantly (0.01>p>0.001) a reduction
of 51.9%. Physiologically CS is released from the
adrenal cortex upon stimulation by ACTH. Acute ad-
ministration of morphine has been reported to elevate
plasma CS level in rats (Briggs and Munson, 1955
George and Way, 1955). Upon chronic administration
however, adrenal cortical steroid secretion in rats
and man gradually falls and presumably this change is
recorded in a lower ACTH and hence lower CS levels.
This is in good agreement with the above observation.
These lower ACTH and CS levels are probably due to
the inhibitory effect of morphine on the hypothalam1kas
since most of the control mechanisms of ACTH secretion
exert their actions there, and that the stimulatory
effect of ACTH secretion by acute administration of
morphine is also related to the function of the hypo-
thalamus. Moreover this inhibition is insensitive to
the close loop feedback interaction of the peripheral
steroid levels as the lowered CS level cannot stimulate
the secretion of ACTH (Dalirtan and Jones, 1973 Gann and
Cryer, 1973 Feldman, 1973). However at this stage the
ACTH secretion is still under the influence of many
stress factors (Kokka and George, 1974).
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Behavioral and biochemical changes in two
periods of morphine abstinence. Experience obtained
from clinical observations has suggested that the
effect of AES is most satisfactory when it is applied
to drug addicts before they have entered vigorous
withdrawal state (Wen, H.L., personal communication).
In the previous experiment, a 4-hour abstinence was
arbitrary chosen. During this period, withdrawal
symptoms had not yet developed. It was observed that
a longer period, tentatively 14 hours, was necessary
for more complete withdrawal symptoms such as wet
dog shakes, teeth chattering, and diarrhea to occur.
However, a comparison of the plasma ACTII and CS levels
of these two rat groups has shown no significant dif-
ference (Table 7). These values are all lower than
the normal individuals. Furthermore, if the mean
ACTH value (181.6 pg/ml) at the 14 hour is selected
to compare with the untreated control, a test of sig-
nificance shows pO.001. This is a further support
of the conclusion drawn in the last section that
chronic addicted rats has lower plasma ACTT-I levels.
Various reports have indicated that naloxone-
precipitated withdrawal in rats as well as abrupt
withdrawal in human show marked elevation in plasma
CS levels (Wen, et al., 1977 Eisenman et al., 1961).
To account for the low CS levels in both 4 and 14-
39
Table 7. Plasma ACTH and Corticosterone Levels in Morphine Addicted Rats
4 Hours and 14 Hours after the Last Dose of Morphine Injection*
Compound#
4 hours
14 hours Test of
N Mean S.D. S.E. N Mean S.D. S.E. Significance@
ACTH 6 265 114.6 46.8 18 181.6 114.5 27 n.s.
(pg/ml)
cs
6 41.1 15.6 6.4 18 53.1 22.5 5.3 n.s.
(ug/l00m1)
* 8 weeks of addiction.
Values in parentheses are units of concentrations.
The significance level of the difference was evaluated by the Student's t testn.s.,not significant
40
hour periods, it is probable that the biochemical
levels of these individuals are still under inhi-
bitory control, with the 14-hour abstinent group
closer to the moment of uprising since its behavior
begins to score withdrawal symptoms. A further
experiment employing naloxone to precipitate with-
drawal in addicted rats, a methods recently applied
clinically to induce more complete withdrawal, has
revealed that this latter process, being more ex-
haustive, has triggered higher degree of withdrawal
and accordingly a significant rise in plasma levels
of ACTII and CS (Table 8). This suggests that the
natural withdrawal occurred at the 14-hour period may
very likely be at a mild withdrawal state. 9 And that
the primary chemical of action yet to be fourrd Te a
exerted its effect on the scoring of the behaviortti
withdrawal while both AOTH and CS, being secondary
in nature, have their changes lagging behind
Effect of AES on naturally withdra-inc rats.
In order to animate the effect of AES on human mor-
phine addicts, an experiment was designed to study
the AES effect both behaviorally and biochemically
on natural withdrawing rats. Table 9 and Fig. 8
report on these findings. There is a definite sup-
pression of withdrawal symptoms with high statistical
41
T able 8 . A C omparisonof the B ehaviorand the P lasma B iochemicalsn M orphineA ddictedR ats
S howing N atural and N aloxone - precipitatedW ithdrawal*
C ontrol W ith N aloxone# T est of
N M ean S . U . S . E . N M eanS . D . S . E . S ignificance□
W ithdrawal
S yrnptoms, 1 2 6 . 3 5 1 . 4 6 1 5 . 3 1 . 8 0 . 7 0 . 0 0 1 > p
( scores/ 3 0 min. )
ACTH 1 8 1 8 1 . 6 1 1 4 . 2 7 1 2 5 3 3 . 1 1 6 4 . 8 4 7 . 6 o . ool> p
( pg/ mi)
CS 1 8 5 3 . 5 2 2 . 5 5 . 3 1 2 6 8 . 2 1 0 . 7 3 . 1 0 . 0 5 > p > 0 . 0 2
( g 4 / 1 OOml)
8 weeks of addiction, 1 4 hours abstainedfrom morphine.
0 . 2 mg naloxoneper rat , i . P .
T he significancelev l of the differencewas evaluatedby the S tudent ' s t test .
S core of withdrawalbehavior is describedin the text .
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Table 9. A comparison of the Behavior and Plasma Biochemicals in Natural Withdrawal Rats with and without
AES Treatment*
Control With AES# Test of
N Mean S.D. S.E. N Mean S.D. S.E. Significance@
Behavior 10 12.9 8.3 2.6 10 6.9 5.6 1.8 0.1p0.05(scores/30 min.)
ACTH 18 181.6 114.5 27 26 371.4 192.9 37.8 0.001p
(pg/ml)
CS 18 53.5 22.5 5.3 26 79.7 28.3 5.6 0.01p0.001(ug/100ml)
8 weeks of addiction, 14 hours abstained from morphine.
High voltage, see text.
Evaluated by the Student's t test.
Individual served as control for itself.
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Fig. 8. A Comparison of the Behavior and Plasma Biochemicals
in Natural Withdrawal Rats with and without AES
Treatment
Data used for this figure are presented in Table 9.
Number of samples is presented in parentheses above the bars.
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significance (0.1p0.05). This suppression goes
along with a significant rise in ACTH (0.001>p) and
CS (0.01>p>0.001). It is of primary interest that
while AES suppresses the natural withdrawal symptoms
in rats, its mode of action, at the ACTH and CS level,
is similar to that observed in a naloxone-precipitated
withdrawal state. That is to say, the same hormonal
increase result is found disregarded the animal's
behavioral pattern, one at naloxone-precipitated
withdrawal state and the other at suppression of
withdrawal by AES.
An attempted explanation will have to consider
the role played by these hormones to be secondary in
nature. bile a biochemical moiety as described in
previous paragraphs dictates the withdrawal expression,
the ACTH and CS levels only reflect the general state
of the stress-related physiology of the animal. The
dictator-biochemical moiety is in turn regulated by
the chronic morphine addiction as well as adjusted by
AES treatment. The net result of this dictator-bioche-
mical controlled withdrawal effect is later exhibited
in the hormonal level. It appears that the rate of
the withdrawal (stress) state-related changes in
hormonal levels is process dependent, with a rapid
pickup (30 minutes) in an AES treatment and a slow de-
velopment( 14 hours) in a natural withdrawal condition.
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It is conceivable that upon chronic morp]i
diction, there is a hypothalamic inhibition of basal
secretion of ACTH which is insensitive to the f ack
of low plasma CS level. At this state, however
res-
ponse to external stress is still functioning a
fested by an increase of ACTH upon stimulation.
.-o me-
chanisms have been suggested to explain the
ory
control of plasma ACT11 level. They are namely
inhi-
bitory effect by the hypothalamus and an exciter, eff-
ect by the external stress, with the latter ex(
gits
action also through the hypothalrmus. The stres sulted
from abrupt morphine withdrawal is rye.urogenic
auses
excitatory neural inputs to be converged on the
the-
lamus. This stimulates the median erinence of
hypo-
thalamus to secrete corticotropic releasing fact
(CRF)
and is transported through the hypophyseal-por
ystem
to the anterior pituitary. The CM then cause ACTH-
secreting cells to release ACTH whichin turn
dates
the adrenals to secrete CS. These evated levi
of
plasma ACTH and CS are essential to prepare the
an-
ism to survive through in emergency situation ed
by the stress (withdrawal syndrome in this casc) In
nature, this external stimulating effect can ov
ide
the inhibitory effect due to chronic morphine
ion, and tentatively, can explain why an inject
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of naloxone elevates the plasma hormonal content.
Other stressful stimuli such as cold exposure (Kokka
and George, 1974) can also cause an elevation of ACTH.
Is AES treatment b itself an external stress-
causing stimulus. The fact that AES treatment not only
reduces the withdrawal symptoms in addicted rats but
also raises their plasma ACTH and CS levels may open
up the possibility of a dual function of the AES pro-
cess. Primarily it regulates, reduces or corrects
the withdrawal symptoms through the formerly postulated
dictator-biochemical and secondarily the AES process
itself exhibitsa stress thus leading to an increase of
plasma ACTH. In view of the fact that stress genera-
tion from experimented rats is hard to monitor or
quantitate, a control experiment was devised to ex-
plore its likeliness. The results presented in Table
10 and Fig. 9 show no significant difference between
the two groups of normal rats with or without AES
treatment. This rules out the possibility of stress
generated from AES treatment in normal rats. Never-
theless, the absence of hormonal change in normal rats
compared to a change in withdrawal rats in the AES
treatment indicates that no matter what the effect of
AES is, it is very likely that it channels through
morphine induced physiological state. Preferably this
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Table 10. Plasma ACTH and Corticosterone Levels of Normal Rats with and without AES Treatment
Control With AE S Test of
Compound*
N Mean S.D. S.E. N Mean S.D. S.E. Significance#
ACTH 37 454.7 262.7 43. 14 340.4 162.3 43.4 n.s.(pg/ml)
CS 46 85.4 40.6 6 26 83.6 39.8 7.8 n.s.(ug/l00mi)
* Values in parentheses are units of concentrations.
#The significance level of the difference was evaluated by the Student's t test, n.s.,not significant.
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Fig. 9. Plasma ACTH and CS Levels of Normal Rats
with and without AES Treatment
Data used for this figure are presented in
Table 10. Number of samples is presented in
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is taken to mean that the AES effect is not through
a simple stress generating process but a more compli-
cated pathway(s) involving a regulation" of physiolo-
gical and biochemical changes due to morphine addiction.
It has well been recognized that acupuncture
has a general "regulatory effect on a lot of diseases
with a proper choice of stimulation at various acu-
punctural points (O'Connor and Bensky, 1975). In drug
addict treatment, this "regulatory" effect covers a
great variety of pathological, physiological and bio-
chemical changes including those in the CNS (Jacquet
and Lajtha, 1973), the endocrine system (Bruni et al:
1977), nucleic acid and proteins (Cox and Osman, 1970 ,
Gisburg and Cox, 1972), metallic ions (Harris et al.
1977 Hitzemann et al., 1974), cyclic nucleotides
(Nerali et al., 1975 Mehta and Johnson, 1975) as i e 11
as the neurotransmitters (Cheney et al., 1975; Carroll
and Sharp, 1972 Leong Way, 1972). So, in the case of
AES treated natural withdrawal rats, part of the "re u-s
latory" effect is indicated by a restoration of normal
level of plasma ACTH and Co levels. Tentatively this
adjustment of ACTH level by AES can antagonize the in-
hibitory effect of morphine.
Effect of naloxone on plasma ACTH and CS levels
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in normal rats. Naloxone was introduced clinically
as a morphine antagonist for the precipitation of
withdrawal symptoms in human addicts successfully
(Hammond, 1971). Similar studies with rats have in-
dicated that such a treatment in rats produces a
more uniform and consistent behavioral withdrawal
symptoms (see previous paragraph). To understand
the nature of naloxone on the plasma biochemicals of
addicted rats, an experiment was designed to study the
same parameters in the normal rat counterpart. Table
11 lists the plasma ACTH and CS concentrations of the
two normal rat groups with and without naloxone in-
jection. This result is further represented in Fig.
10. It shows essentially no effect.
Effect of AES on naloxone-precipitated withhv.
drawal in rats. It has been observed clinically that
AES effectively alleviates the withdrawal symptoms
precipitated by naloxone in morphine addicted patients
(Wen and Cheung, 1973 ab). In rats, a proper condi-
tion was chosen to give an optimal withdrawal response
in addicted animals as judged by the extensiveness of
the behavior of these addicted individuals. The dosage
of naloxone used as well as the duration of addiction
appear to be crucial for the effectiveness of the AES
treatment. This is consistent with the observation
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T able 1 1 . P lasma ACTH and C orticosteroneL evels of N ormal R ats and N ormal R ats I njectedwith
N aloxone*
L ontrol W ith N aloxone T est of
C ompound# N M ean S . D . S . E . N M ean S . D . S . E . S ignificance□
ACTH 3 7 4 5 4 . 7 2 6 2 . 7 4 3 . 2 7 3 0 9 1 2 5 . 2 4 7 . 3 n . s .
( pg/ ml)
CS 4 6 8 5 . 4 4 0 . 6 6 7 1 1 0 . 2 2 6 9 . 8 n . s .
( pg/ l 0 0 ml)
* 0 . 2 mg/ rati . p .
V alues in p , : 1 L enthesesare units of concentrations.
□ T he significancelevel of the differencewas evaluatedby the S tudent ' s t test
n . s . , not significant,
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Fig. 10. Plasma ACTH and CS Levels of Normal Rats
and Normal Rats Injected with Naloxone
Data used for this figure are presented in
Table 11. Number of samples is presented in



























that analgesia produced byacpuaacture is blockod
by naloxone (Pomeran z and (Ihhiu, 1976 Sjolund et al.
1977). Clinical studies in progress have also indicated
that a better ''detoxification' process has been
developed in treating drug addicts by carefully
monitoring the dosage of naloxone applied to achieve:
a suitable withdrawal interdsi in the patient for
more effective AIS treatment (Hon 1977)is was found
that rats addicted for 2 weeks, followed by a 22-hour
abstinence from morphine, crave proper and constant
withdrawal responses upon an :intrapperitonea.l injection
of naloxone (0.01 mg/rat) and that this wirithdrawwal
behavior can be successfully suppressed by AES
treatment at low voltage. Both high and low voltage
are as effective but the latter was chosen to eliminate
any complication due to possible electrical side effects.
Behavioral studies were done as described in. Materials
and Methods except a ,shorter observation period
(15 minutes) was employed. .the results are recorded
in Table 12 and depicted in Fig 11
To begin with, the behavioral and biochemical
levels of the nai.oxone-prec:Lpitaated rats are higher-
than that in the chronic morphine addicted rats (see
Table 8). AES reduce: the beliaviora],. re:sponnises to
42.2/, ACTH to 33% and CS to r 76.2%' correspondiogly.
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T able 1 2 , A C omparisonf B ehavioral. and P lasma B iochemicalsin N aloxone- precipitatedW ithdrawal
R ats with and withoutAES T reatment*
C ontrol W irh AES T est of
E M ean S . D . S . E . N M ean S . D . , S . E . S ignificance
W ithdrawal
S ymp tons 5 1 6 . 6 7 3 . 1 5 7 4 . 5 2 . 0 O . O 5 > p > 0 . 0 2
( scores/ l 5 min. )
ACTH 5 9 3 8 . 8 3 2 8 . 4 1 4 6 . 9 5 3 0 9 . 7 1 2 5 . 4 5 6 . 1 0 . 0 > p > 0 . 0 0 1
( pg/ ml)
CS 5 1 1 8 . 5 1 4 . 7 6 . 6 5 9 0 . 3 1 7 . 1 7 . 6
( ug/ l OOml)
T he rats were renderedmorphinedependentby 2 weeks of i . p . injection. T hey were abstainedfrom
morphinefor 2 2 hours . W ithdrawalwas precipitatedby 0 . 0 1 . mg naloxone/ rat i . p . , and observed
for 1 5 minutes. L ow voltage was used during AES treatment.
50
Fig. 11. A Comparison of the Behavior and Plasma Biochemicals
in Naloxone-precipitated Withdrawal Rats with and
without AES Treatment
Data used for this figure are presented in Table 12.
:Number of samples is presented in parentheses above the bars.
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This comparison clearly demonstrates that a suppression
in the behavioral level can be qualitatively expressed
by the plasma ACTH and CS levels. To account for this
observation, the plasma ACTII, which in turn governs
the plasma CS level, can play either one of the
following roles: its level determines the extell sivreness
of the withdrawal syndrome, or its level is actually a
direct indication of a chain of reactions initiated
by the withdrawal syndrome. A more detail comparison
of the behavioral responses and the plasma ACTH and
CS levels at various Stages of the experiment is
in pig. 12. In this case, even though application. of
AES treatment can alleviate both natural and nalonon
precipitated withdrawals with equal success, yet the
changes of the plasma biochemicals are, in fact, in.
opposite directions. In natural withdrawing rats,
the effect of AE S is an increase in plas-ma ACTH and
CS levels while in naloxone-precipitated withdral:wal,
the effect is a reduction. This finding suggests
that both the biochemical levels as well as their
bidirectional changes shoild not be considered as a
main factor in generating AES beneficial effect.
It is more reasonable to accept a concept that
AES plays a general regulatory role in the animal
system and very likely it works through some dictator-
Fig. 12. A Comparison of the Behavior and Plasma Biochemical
at Various States in the Experiment
Number of samples is presented in parentheses above the
bars. R, normal rats; RA, normal rats treated with AES (3-4
volts); RN, normal rats injected with naloxone (0.2 mgrat,
i.p.); M4, 8-week addicted rats, 4 hours after morphine;
M, 8-week addicted rats, 14 hours after morphine; N, 2-week
addicted rats, 22 hours after morphine, withdrawal precipitatec









































biochemical(s) yet to be found. This dictator-
biochemical has a general function of regulating man)
mal-functions in different systems as described in
previous paragraphs. As a result of the alleviation
of the withdrawal symptoms and the regulatory
effect, the plasma ACTK and CS regain their presumably
n o rma1 levels.
Section B: EXPERIMENTS WITH MICE
Optima 1 na 1 oxone dosage for AES a 11 eviatin g
wi thdrawal trea tment Experirnents were done with
mice to study the generality of the rehabilitation
effect of ACS on various animal types. As discussed
in the previous section, the amount of naloxone is
crucial for the quality of the AES effect. This
becomes more important in a small body size animal
such as mouse. Fig. 13 represents two withdraw-
scoring curves in the presence and absence of AES
treatment. A comparison of the values indicates that
10 mgKg body weight is the optimal naloxone dosage
for expressing the AES effect. This amount of naloxon
was thus used for further« xperimentation with mice.
Effect of AES on plasma biochemica1s from
naloxone-precipitated withdrawing mice. A study of
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Fig. 13. Total Scores of Naloxone-precipitated Withdrawal
n: number of mice statistically significant
C----C-----C: withdrawal scores without AES
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the plasma ACTH in morphine addic ted mice reveals chat
it is lower ( 4 6 . 8 pg / mi ) than the non - addictedcontrol
( 1 1 4 . 7 p S / m 1 ) . T his observation, is in good agreement
with the results obtained in rats as well as in man .
S imilarly , non - addicted control shows no significant
plasma ACTH change upon an . in jectiorn of naioxone 6 .
H owever , naloxone caused a ten - fold increase of plasma
ACTS in morphineaddictedmice ( 4 6 . 8 to 4 4 6 . 6 pg / mi )
as shown in T able 1 3 . T his increase is significantly
reduced by AES to approximatelythe normal level
( 1 8 6 . 6 pg / mi ) .
I dentical observations were obtained in human
addicts and innaloxone- preecl prpi tated withdrawingrats s ,
E ven though the natural withdrawal mice have not been
tested , it seems most likely that the function of
AES transcends animal origin and ha s a general
regulating effect on withdrawal animals .
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Table 13. Effect of AES on Plasma ACTH of Addicted. Mice
during Withdrawal
Group ACTH (pg/ml)±S.D
Addicted+ naloxone 446.4± 236.5
Addicted+ naloxone+ AES 186.6 4_ 143.2 (8)
68
CONCLUSION
The effects of AES have been successfully de-
monstrated in at least two aspects: a general analgesic
effect and a regulatory effect in alleviating withdrawal
symptoms from morphine addicts. This investigation
has established two animal models for further studies
on the regulating mechanisms and has demonstrated the
resulting plasma hormonal changes at various stages
of morphine addiction. In general, an AES effect
requires a pariod of induction, ?-30 minutes in the
bchrvioral stadies and presumably sirilar time intermal
in the pias?? biochemical cnanges.
In vier of the observation that the general
analgesic effect can be blocked by naloxone and that
morpbine-Like peptioes are involved in the analgssic
process, it is conceivable that a humoral p?thway mry
the antorior pituitary (Gui lemin et al., 1977; Krieger,
et al?, 1977). As ditinct from enkephalin, a pcnta-
peptide located in the mervous system which rapidly
loses its morphine-like action in the blood, B-endorphin
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is highly resistant to peptide degradative enzymes
found in the circulatory system. Since analgesic
effect can be observed in a recipient ar. imal with
blood cross-circulated from another animal under
AES induced analgesia (Lung et al. 1973), it is
expected that there is a stable functional bioeical.
moiety circulating in the blood and serves as a
messenger to induce an analgesic effect on the re-
cipient. This messenger type bdcchemical may very
well be the humzoral opiate factor and accordingly,
the noticeable B-endorphin.
It in reported that ACTH and I exridorp he
both secreted conooeittautly fron nonmca ratn (Goillo-
min, et ale, 1977). Our findinzs on the t. hang's of
plasma. ACTH lcvcla do not strongly-
proposal thet LES has an offoct only in inducils
ACTU thus B-endorphin secretion..,
Experiments conducted by Hayer (l995) as poll
Yaksh et al. (1976) have show that focal electricr
Stimulation of the mesenncepihalic and periaqeductal
central gray ratter in the rain induces analgesia
which is at most only partially reversed by naloxone.
This finding suggests that other than the humoral path-
way may be employed in inducing analgesia, tentatively,
there is a "non-humoral" pathway. Consequently, this
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"non-humoral"pathway should not be antagonized by
naloxone. And the partial inhibition observed can be
explained on the basis of the collaboration of both
pathways. This is not unusual since in signal trans-
duction, it has been documented that in bacterial
chemotaxis, two reception processes are involved in
the detection of one attractant, nawely, glucose(Adlor
et al.,1973). one of the suggestions is that these
two pathways, humoral and "non-humoral",contribute
to different extcnts at different physiological states.
In naloxone-precipitanted withdrawal, AES exerts its
alleviating cffcct through this "non-humoral"pathway
with a reduction in the plasma ACTH and thus - cndorphin
levels.
Aprimitive modcl which accounts for the above
observations appcars to includc:
a.An inducer which can cither be quantitatively or
qualitatively charged to different extent by a
natural withdrawal process or in the presence of
naloxone. This charged hnducer will govern the
extensiveness of the withdrawal symptoms.
b. An intensified withdraral will in turn trigger
an increase in the plasma ACTHlevel of the
addict. However this increase is withdrawal-
process dependent. In a naloxone-precipitated
withdrawal, the effect is .r.iirteci Cite while jr,
n natural withdrawal, it iekes a considorsble
time.
C. AES reduces the effect of the inducer in
generating withdrawal symptom s, This reduc-
tion creates a regulating mechanism which
sends the plasma ACTII back to normal level,
d. Apparently, there is an internal standa-,d for
normal ACTII level in each individual. Chronic
addiction lowers this level while withdra`tal
eventually raises it. Both conditions are off
norria.1_.. A regulating effect as mentioned sn.
(c) exerts its influence on this syster,
by removing the factor (s) which l_a.s upset t`se
normal ACTJ-I in either dir ec ti on. This Ji_s.
analogy to bringing a sprin back to its most
stable situation no mat ter the previous up-
setting force is pulling or puslhing.
The inducer r.-noiety mentioned in the model ca:-.
be as simple as a protein, tentatively a receptor-
type protein. Presumably, e -I AES effect is to sen-nd
off signal for inducing a Co iforrnational change in
this protein to vary its affinity to its corres-
ponding substrates. This variation governs the
behavioral phenomenon. The signal can be as sub-
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stantial as a samll molecule which binds to the
inducer. This model is very primitive and is
specifically constructed to explain the major find-
ings described in this thesis. Phenomena such as
tolerance and physical dependence were not taken into
consideration. In order to set up a more sophisticated
model for the effect of AES on drug rehabilitation,
information from the binding and action of opiate
receptor, the secretion and general function of
morphine-like peptides and a complete analgesia
pathway would be helpful. Hopefully, future work
may enrich our knowledge in these aspects.
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